FSWA
Financial Synergies Wealth Advisors Portfolio holdings
AUM
$918M
This Quarter Return
-3.78%
1 Year Return
+13.84%
3 Year Return
+48.65%
5 Year Return
+63.97%
10 Year Return
–
AUM
$693M
AUM Growth
+$693M
(-2.9%)
Cap. Flow
+$6.97M
Cap. Flow
% of AUM
1.01%
Top 10 Holdings %
Top 10 Hldgs %
74.07%
Holding
525
New
30
Increased
135
Reduced
54
Closed
25
Top Buys
| 1 |
Vanguard Mid-Cap ETF
VO
|
$1.71M |
| 2 |
Dimensional Core Fixed Income ETF
DFCF
|
$1.5M |
| 3 |
Vanguard Value ETF
VTV
|
$905K |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$826K |
| 5 |
Exxon Mobil
XOM
|
$710K |
Top Sells
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
$1.03M |
| 2 |
Vanguard Small-Cap ETF
VB
|
$826K |
| 3 |
Vanguard Small-Cap Value ETF
VBR
|
$587K |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
$548K |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$344K |
Sector Composition
| 1 | Energy | 1.04% |
| 2 | Technology | 0.4% |
| 3 | Consumer Discretionary | 0.31% |
| 4 | Financials | 0.23% |
| 5 | Healthcare | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Akamai
AKAM
$11B
| $1.6K | ﹤0.01% |
15
| – | – |
|
327
Amphenol
APH
$133B
| $1.6K | ﹤0.01% |
19
| – | – |
|
328
Welltower
WELL
$112B
| $1.56K | ﹤0.01% |
+19
| New | +$1.56K |
|
329
SAP
SAP
$310B
| $1.55K | ﹤0.01% |
12
| – | – |
|
330
KRONOS Worldwide
KRO
$713M
| $1.55K | ﹤0.01% |
+200
| New | +$1.55K |
|
331
Intuit
INTU
$185B
| $1.53K | ﹤0.01% |
3
| – | – |
|
332
Progressive
PGR
$144B
| $1.53K | ﹤0.01% |
11
| – | – |
|
|
HZNP
333
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.5K | ﹤0.01% |
13
| – | – |
|
334
West Pharmaceutical
WST
$17.5B
| $1.5K | ﹤0.01% |
4
| – | – |
|
335
Haleon
HLN
$43.7B
| $1.5K | ﹤0.01% |
+180
| New | +$1.5K |
|
336
American Tower
AMT
$93.9B
| $1.48K | ﹤0.01% |
9
+3
| +50% | +$494 |
|
337
Equinix
EQIX
$75.5B
| $1.45K | ﹤0.01% |
2
| – | – |
|
338
Honda
HMC
$44.9B
| $1.45K | ﹤0.01% |
43
| – | – |
|
339
UBS Group
UBS
$126B
| $1.41K | ﹤0.01% |
57
| – | – |
|
340
Royalty Pharma
RPRX
$15.6B
| $1.39K | ﹤0.01% |
51
+25
| +96% | +$679 |
|
341
IQVIA
IQV
$31.2B
| $1.38K | ﹤0.01% |
7
| – | – |
|
342
Synopsys
SNPS
$110B
| $1.38K | ﹤0.01% |
3
| – | – |
|
343
Super Micro Computer
SMCI
$24.2B
| $1.37K | ﹤0.01% |
5
-1
| -17% | -$274 |
|
344
Stryker
SYK
$149B
| $1.37K | ﹤0.01% |
5
-5
| -50% | -$1.37K |
|
345
Avantor
AVTR
$9.06B
| $1.35K | ﹤0.01% |
64
| – | – |
|
346
GoDaddy
GDDY
$20B
| $1.34K | ﹤0.01% |
18
| – | – |
|
347
Goldman Sachs
GS
$221B
| $1.3K | ﹤0.01% |
4
| – | – |
|
348
PACCAR
PCAR
$51.9B
| $1.28K | ﹤0.01% |
15
| – | – |
|
349
Valero Energy
VLO
$47.9B
| $1.28K | ﹤0.01% |
9
| – | – |
|
350
Lam Research
LRCX
$123B
| $1.25K | ﹤0.01% |
2
| – | – |
|